RDIF and partners launch Alium pharmaceutical holding
Moscow, October 14, 2019 - A consortium of investors, including the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), the Russia-China Investment Fund (RCIF) established by RDIF and China Investment Corporation (CIC), and leading Middle Eastern funds in partnership with Sistema and VTB Bank, have announced the launch of the Alium pharmaceutical holding.
The Alium holding is the product of a merger between the pharmaceutical companies Obolenskoe and Binnopharm. Following the merger, Alium is among the top-10 Russian pharmaceutical companies in the sector.
The consortium led by RDIF holds a 23% stake in Alium, with Sistema and VTB Bank holding 26.3% and 38.5% respectively. The holding has a diversified product portfolio of 200 pharmaceuticals. The production capacity of the merged company is based on the four facilities in Moscow and the Moscow region.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said:
“The establishment of one of the leading diversified pharmaceutical holdings will enable us to develop the production of high-quality drugs in Russia to improve the quality and life expectancy of the people. The participation of RDIF’s international partners in this project confirms their interest in investing in Russian medicine and pharmaceuticals, as well as their willingness to work together with RDIF to implement Russian national projects”.
Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. Currently, RDIF has experience of the successful joint implementation of more than 70 projects with foreign partners totaling more than RUB1.5 tn and covering 95% of the regions of the Russian Federation. RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia’s GDP. RDIF established joint strategic partnerships with leading international co-investors from more than 15 countries that total more than $40 bn. Further information can be found at rdif.ru
For additional information contact:
Russian Direct Investment Fund
Tel: +7 495 644 34 14, ext. 2395
Mobile: +7 916 110 31 41
Andrew Leach / Maria Shiryaevskaya
Tel: +44 (0) 20 7796 4133